Answers are grounded in this paper and cite their sources.
Home-based intraocular pressure (IOP) monitoring has emerged as a promising approach for improving glaucoma management by providing information on IOP fluctuations that may not be captured during routine clinic visits. Relevant literature on home-based IOP monitoring technologies was reviewed with emphasis on device principles, clinical validation, and potential clinical applications. Devices, such as I Care HOME (Rebound Tonometer), enable intermittent self-measurement of IOP, while wearable systems, like Triggerfish, provide continuous trend data. Implantable sensors, such as EyeMate and InjectSense (IOP-Connect), offer direct and continuous IOP monitoring in mmHg. Each modality has unique advantages and limitations in terms of accuracy, usability, and clinical applicability. Home IOP monitoring provides valuable insights into IOP fluctuations and may improve glaucoma management. However, no current device fulfils all ideal criteria, and further advancements are required for widespread clinical adoption.
No takes yet. Share an insight, caveat, or question.
Maheswari et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: